home / stock / mgtx / mgtx news


MGTX News and Press, MeiraGTx Holdings plc From 11/07/19

Stock Information

Company Name: MeiraGTx Holdings plc
Stock Symbol: MGTX
Market: NASDAQ
Website: meiragtx.com

Menu

MGTX MGTX Quote MGTX Short MGTX News MGTX Articles MGTX Message Board
Get MGTX Alerts

News, Short Squeeze, Breakout and More Instantly...

MGTX - MeiraGTx Reports Third Quarter 2019 Financial Results

LONDON and NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results for the quarter ended September 30, 2019 and provided an update on recent progress. ...

MGTX - Why Did the Market Whack This IPO?

The bankers priced Vir Biotechnology (NASDAQ: VIR) at $20 a share for its IPO on Friday. There was no demand for the name. The stock opened at $16.20 a share and proceeded to drop to $14.02 a share by the end of the day. It was almost a 30% loss for early investors. Prior to the IPO, Arch V...

MGTX - Key events this week - healthcare

Noteworthy events during the week of October 6 - 12 for healthcare investors. More news on: Alnylam Pharmaceuticals, Inc., Summit Therapeutics, XBiotech Inc., Healthcare stocks news, , Read more ...

MGTX - MeiraGTx to Present at Upcoming Scientific and Investor Conferences

LONDON and NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that the Company will present at the following upcoming events: 3rd Annual Chardan Genetic Medicines Conference in N...

MGTX - 2 Small-Cap Biotechs With Huge Upside

The world of biotech investing can be tricky. And that's particularly true for small-cap stocks in the biotech sector. These companies often have terrific science, but no profits and little if any revenues. And yet there are outstanding opportunities in this sector for investors who know what ...

MGTX - Three Q4'19 Catalysts For Axovant

Axovant Gene Therapies ( AXGT ) is running three clinical programs on three gene therapy candidates for neurological and developmental disorders. Readouts from all three programs are expected in Q4'19, presenting an opportunity for a trade, which is the focus of this article. A big Q4'19 u...

MGTX - MeiraGTx To Present Clinical Data from Phase 1/2 Trial of AAV-RPE65 at Upcoming Scientific Conferences

LONDON and NEW YORK, Sept. 10, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that clinical data updates from the Company’s Phase 1/2 trial of AAV-RPE65 will be presented at two upcomin...

MGTX - Sell-siders like InMode in premarket analyst action

Correvio Pharma (NASDAQ: CORV ) initiated with Overweight rating and $6 (193% upside) price target at Cantor Fitzgerald. More news on: Correvio Pharma Corp., InMode Ltd., MeiraGTx Holdings plc, Healthcare stocks news, Stocks on the move, , Read more ...

MGTX - Daily Insider Ratings Round Up 8/20/19

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

MGTX - Earnings dominate premarket losers

Green Dot (NYSE: GDOT )  -48%  on Q2 earnings . More news on: Green Dot Corporation, ICU Medical, Inc., Rayonier Advanced Materials Inc., Stocks on the move, Read more ...

Previous 10 Next 10